Optimising Molecular Radionuclide Therapy
Conditions: Neuroendocrine Tumors; Hyperthyroidism; Thyroid Cancer; Thyroid Carcinoma Interventions: Diagnostic Test: Nuclear Medicine whole-body; Diagnostic Test: SPECT/CT imaging.; Diagnostic Test: PET/CT imaging.; Device: Patient-led radiation monitor (SELFIE); Diagnostic Test: LAB TEST Sponsors: King's College London; Guy's and St Thomas' NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2021 Category: Research Source Type: clinical trials